Clinical Trials
39 trialsSoluble B7-H3 as a Biomarker for Osteosarcoma
Peking University People's Hospital
Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate
BTG International Inc.
Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Blokhin's Russian Cancer Research Center
3D Printed Implants for the Defect Reconstruction in Patients With Chest Wall Tumors
Blokhin's Russian Cancer Research Center
PalboSarc
Grupo Espanol de Investigacion en Sarcomas
Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma
The First Affiliated Hospital of Xinxiang Medical College
Tucidinostat Plus Apatinib for Advanced Osteosarcoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
PROACH
Ruijin Hospital
Circulating Exosome RNA in Lung Metastases of Primary High-Grade Osteosarcoma
Ruijin Hospital
Metabol-Sarc
Istituto Ortopedico Rizzoli
SYNERGIAS
Grupo Espanol de Investigacion en Sarcomas
TANOs
Université de Reims Champagne-Ardenne
Predictive Models of Treatment Responses and Survival Outcomes in Patients With Osteosarcoma
West China Hospital
Efficacy of Epidural Analgesia in Lower Extremity Osteosarcoma
Istanbul University
SARCOMAS
University Hospital, Strasbourg, France
Efficacy of Exercise Program on Osteosarcoma Patients
Cairo University
TQBSP
Peking University People's Hospital
Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR
Second Affiliated Hospital, School of Medicine, Zhejiang University
MAPAC
Peking University People's Hospital
Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of Osteosarcoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
A Phase I Clinical Trial of Neoadjuvant Chemotherapy With/Without SPIONs/SMF for Patients With Osteosarcoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma
Sun Yat-sen University
EBAOFC
Peking University People's Hospital
PRESOV
Assistance Publique - Hôpitaux de Paris
PROS001
Second Affiliated Hospital, School of Medicine, Zhejiang University
CESOFB
Peking University People's Hospital
Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors
Samsung Medical Center
Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum
Peking University People's Hospital
PD-L1 Expression in Advanced Osteosarcoma
Peking University People's Hospital
The Osteosarcoma Biobank in Peking University People's Hospital
Peking University People's Hospital
Patient-derived Xenograft (PDX) Modeling to Test Drug Response for High-grade Osteosarcoma
Peking University People's Hospital
Epigenetic Biomarker for Osteosarcoma
Peking University People's Hospital
GLATO2017
Grupo de Apoio ao Adolescente e a Crianca com Cancer
Li2CO3
Sun Yat-sen University
A Clinical Research on the Relation of Blood Drug Concentration and Calcium Folinate Rescued in High-dose MTX Therapy
Tianjin Medical University Cancer Institute and Hospital
Long Term Neurotoxic Effects of Chemotherapy in Survivors of Bone and Soft Tissue Sarcomas. A Retrospective Study
Universitaire Ziekenhuizen KU Leuven
Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Osteosarcoma
Hospital Santa Marcelina
FUBEO
Universitaire Ziekenhuizen KU Leuven
Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse
Gustave Roussy, Cancer Campus, Grand Paris